Search This Blog

Wednesday, November 6, 2019

Cellular Biomedicine EPS misses by $0.15

Cellular Biomedicine (NASDAQ:CBMG): Q3 GAAP EPS of -$0.82 misses by $0.15.
Cash and equivalents of $29.04M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)